CONTRACT AWARD

RNS Number : 6045W
Chemring Group PLC
13 February 2017
 

 

13 February 2017

 

Chemring Group PLC

("Chemring" or "the Group")

HMDS Contract Win

 

Chemring Group PLC is pleased to announce that its US subsidiary, Chemring Sensors and Electronic Systems, has received a contract from the US Army for ten ground penetrating radar trial systems, which will incorporate the Group's enhanced detection technology capabilities. The evaluation of this new capability, if successful, could lead to upgrades of the the US Army HMDS inventory.

Michael Flowers, Group Chief Executive of Chemring, commented: "I am delighted that we have received this contract that will support an Operational Assessment by the US Army.  These systems, which incorporate enhanced detection technology developed by Roke and Chemring Technology Solutions in the UK, offer a valuable upgrade to the existing HMDS fleet. The HMDS, a Program of Record for the US Army, is a key part of our long term growth strategy and the continued progression of this capability is encouraging."

 

 

Enquiries:

 

Chemring Group PLC


Michael Flowers

Group Chief Executive

+44 (0)1794 833 901

Rupert Pittman

Group Director of Corporate Affairs

+44 (0)1794 833 901

 




MHP Communications


Andrew Jaques


+44 (0)20 3128 8100

John Olsen



James White






 

Cautionary statement

 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are; increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects. Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

Notes to editors

 

·    Chemring is a global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·    Employing approximately 2,750 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

·    Chemring is now organised under three strategic product segments:  Countermeasures, Sensors & Electronics, and Energetic Systems

·    Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·    Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAOKKDPCBKKKBD
UK 100

Latest directors dealings